Moreover, CA125 serves as a prognostic marker for patients with pancreatic cancer, and mechanistic studies found that the KRAS/MYC axis drives the upregulation of MUC16/CA125 [13]. The gene discussed is MUC16; the disease is familial pancreatic carcinoma.